The Altman Clinical and Translational Research Institute (ACTRI) is part of a national Clinical and Translational Science Award (CTSA) consortium, led by the
National Institutes of HealthNational Center for Advancing Translational Sciences (NCATS). Established in 2010, ACTRI provides infrastructure and support for basic, translational and clinical research throughout the San Diego region to bring discoveries from the laboratory to the bedside, and facilitates training and education of the next generation of researchers. ACTRI carries out its activities in collaboration with institutional and corporate partners and currently has more than 1,300 members. The ACTRI News and Funding Opportunities is a monthly newsletter.
Director’s Message, Winter 2016-2017
Obtaining preliminary data is essential to the success of early-stage clinical studies, and is the cornerstone for receiving federal or foundation support for larger scale studies. Last year, the Altman Clinical and Translational Research Institute (ACTRI) implemented a Vouchers Program to enable researchers to gather preliminary results for grant submissions. These vouchers provide support for research services for in-kind services only, including those related to the ACTRI clinic, laboratory, biostatistics and bioinformatics, and the Center for Computational Biology and Bioinformatics (CCBB). Vouchers range from $500 to $10,000, depending on category and type of service.
ACTRI Vouchers for ACTRI Research Services (In-kind)
NEW Allowance for Vouchers to Supplement Two Types of NIH-Funded Studies for Clinical Services Only
Recent Addition of CCBB Vouchers
Eligible: Unfunded Projects Designed to Gather Preliminary Data for Grant Submissions or ACTRI Pilot Projects, Career Development Awards (K-series only; UC San Diego only) and ACTRI KL2 Awardees. In addition, Vouchers can potentially be used to supplement two types of NIH-funded studies for clinical services only.
UC-OptumLabs Call for Proposals
Deadline February 2
NCATS Open Funding Opportunities
ACTRI News and Features
During the reception in the ACTRI building lobby are (from left): ACTRI Director Gary S. Firestein, MD; Day of Translational Science presenters Christina Holub, PhD and Camille Nebeker, EdD; and Day of Translational Science leaders Colin Depp, PhD and Paul Mills, PhD.
ACTRI Day of Translational Science Inspires New Generation of Translational Researchers
Event with Keynote Speaker Venter Draws More Than 100 UC San Diego Researchers
Inspiring research talks by J. Craig Venter and five translational scientists supported by the Altman Clinical and Translational Research Institute (ACTRI) marked the ACTRI Day of Translational Science on January 18. The afternoon event at the ACTRI building drew more than 100 UC San Diego researchers and concluded with a reception and poster session featuring research trainees from the ACTRI TL1 program. The Day opened with mini-presentations by Jona Gattanhadi-Gluth, MD; Drew Hall, PhD; Christina Holub, PhD, and Camille Nebeker, EdD; and Adriana Tremoulet, MD. Their talks focused on studies ranging from Kawasaki disease to Pacific Islander fitness and health, and from smart-phone technology for monitoring cystic fibrosis to minimizing radiation damage to normal brain tissue and cognitive function in brain tumor patients. “One of best ways to inspire new generations of translational scientists is by highlighting the work of young researchers we have supported through our ACTRI education and pilot project programs,” said Paul Mills, PhD, who provided opening remarks and introduced the presenters for the first portion of the day’s program. Mills is a member of the ACTRI Executive Committee and led the event with ACTRI Education Director Colin Depp, PhD. ACTRI clinic, community engagement, education and laboratory staff were also on hand at the reception to discuss resources available to researchers.
View Dr. Venter’s Talk,
From Designing Life to Prolonging Healthy Life, on the
UCTV: Wellbeing Channel
The San Diego Union-Tribune Features the ACTRI Day of Translational Science in an article by Bradley Fikes,
“Center hopes to speed health advances from lab to patients.”
ACTRI Announces New KL2 Award Recipient
The ACTRI has selected Brigid Boland, MD, as the newest recipient of a KL2 award. As part of the ACTRI Education program, KL2 awards provide a tailored mentored research experience to promising faculty clinical and translational researchers. Dr. Boland is studying how to identify early biomarkers of response to a novel medication for Inflammatory Bowel Disease, with the hope of predicting symptom improvement or side effects early in therapy.
Collab@Altman Monthly Mixer Kicks Off February 3
The Altman Clinical and Translational Research Institute (ACTRI) and the Department of Radiology are launching the Collab@Altman Monthly Mixer program on Friday, February 3, at the ACTRI Auditorium and Lobby from noon to 1 p.m. The event will include lunch, presentations, and an opportunity to connect with fellow ACTRI researchers. Collab@Altman encourages an open, collaborative and interdisciplinary community within the ACTRI building. It will occur the first Friday of each month and feature the research of a principal investigator or research group located in the ACTRI building. The February 3 meeting will include an introduction to the ACTRI by Gary S. Firestein, MD, Director of the ACTRI and Dean and Associate Vice Chancellor of Translational Medicine, and an introduction to Collab@Altman by Anders Dale, PhD, Vice Chair for Research and Director for Multimodal Imaging and Genetics. RSVP is appreciated to plan for lunch. The program also seeks future presenters from the building who would like to showcase their research and group. To RSVP for the February 3 event or to express interest in presenting about your collaboration, please send an email to
In This Issue
ACTRI Hosts Communications Seminar for Early Career “K” Awardees
The Altman Clinical and Translational Research Institute (ACTRI) is hosting a year-long career development seminar series, “Communicating: Your Academic Life Depends on It,” for early career “K” awardees from UC San Diego, San Diego State University, and ACTRI partner institutions. The eighth session in the series is scheduled for Tuesday, February 7. The topic is “Communicating with the Public.” The session will take place at the ACTRI building. RSVP is required to firstname.lastname@example.org.
ACTRI Seminar Series
Daniel T. O’Connor Memorial Lecture
From Hypertension to Genomic Medicine
Presented by Howard J. Jacob, PhD, on Thursday, Feb. 23, from noon to 1 p.m. at the Leightag Building, Room 107. Dr. Jacob is the Executive Vice President for Medical Genomics, Chief Medical Genomics Officer, and Faculty Investigator at the HudsonAlpha Institute for Biotechnology. Lunch will be served.
Accelerated Brain and Biological Aging in Serious Mental Illness
Presented by Lisa T. Eyler, PhD, professor of psychiatry, on Tuesday, April 4, from 2:30 p.m. to 3:30 p.m. at the Leichtag Building on the School of Medicine Campus.
Save the Date!
Second Human Research Training Symposium Scheduled for March 28
Mark your calendars! March 28 is the date for the second Human Research Training Program, which was created to help study teams navigate the research processes more easily and efficiently. Details on time, place and registration for the symposium are TBD. This ongoing training series features presentations and information exhibits related to the clinical trials process and is hosted by the Altman Clinical and Translational Research Institute (ACTRI), Human Research Protections Program (HRPP), Office of Coverage Analysis Administration (OCAA), and Office of Clinical Trials Administration (OCTA). To receive an invitation to the symposium, please
subscribe to the training mailing list
Cite the Grant
Don’t forget to cite the grant!
To help ensure resources are available for future research,
please cite the UCSD ACTRI CTSA grant.
Projects and Publications using UCSD ACTRI resources must cite the UCSD ACTRI grant and follow the NIH Public Access Policy.
ACTRI News and Funding Opportunities
Gary S. Firestein, MD
Director of ACTRI
Chief Administrative Officer